Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02482948 · ClinicalTrials.gov registry record · NA

MEDIHONEY® Gel Versus Collagenase for Wound Debridement

A NA study, sponsored by Integra LifeSciences Corporation.

Terminated
Registry status
NA
Development phase
10
Enrollment target

NCT02482948: Clinical Trial NA study, sponsored by Integra LifeSciences Corporation.

NCT02482948 is a NA study that was terminated before completion, run by Integra LifeSciences Corporation. The registered enrollment target is 10 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02482948, a NA study, was terminated before completion, sponsored by Integra LifeSciences Corporation.

TERMINATED
Registry status
NA
Development phase
10 participants
Enrollment target

Study Summary

The purpose of this study is to compare how well two products, Active Leptospermum Honey (ALH) (MEDIHONEY® Gel) and Collagenase (Santyl®), in removing the nonviable (non living) tissue.

Primary Outcome

Necrotic tissue percent reduction in the wound at the end of 14 days

Interventions

  • DRUG Collagenase
  • DEVICE Active Leptospermum Honey (Medihoney)

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2015-06
Est. Completion 2017-03
Phase NA
Integra LifeSciences Corporation

60 total trials

Why NCT02482948 stopped before completion

NCT02482948 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 2 interventions - of which Collagenase is the first listed.

NCT02482948 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02482948 about?

NCT02482948 is a clinical study titled "MEDIHONEY® Gel Versus Collagenase for Wound Debridement". The purpose of this study is to compare how well two products, Active Leptospermum Honey (ALH) (MEDIHONEY® Gel) and Collagenase (Santyl®), in removing the nonviable (non living) tissue.

What is the current status of trial NCT02482948?

This trial is currently terminated. It is a NA study. The enrollment target is 10 participants. The study started on 2015-06. Estimated completion is 2017-03.

What interventions are being tested in trial NCT02482948?

The interventions under investigation include: Collagenase (DRUG), Active Leptospermum Honey (Medihoney) (DEVICE).

Who is sponsoring clinical trial NCT02482948?

This trial is sponsored by Integra LifeSciences Corporation, which has 60 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02482948's enrollment target sits among peer trials

10 1927th of 2000 higher than 26 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00623389 · 10 participants · NA

    Evaluation of an Advanced Lower Extremity Neuroprostheses

  • NCT01241864 · 10 participants · Phase 2

    Islet Transplantation in Type 1 Diabetic Kidney Allograft

  • NCT01293214 · 10 participants · NA

    Vascularized Composite Allotransplantation for Multiple Extremity Amputations

  • NCT01474148 · 10 participants · NA

    A Neuroprosthesis for Seated Posture and Balance

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02482948, the US trial registry maintained by the National Library of Medicine. NCT02482948 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.